GlassScriptPhysician profile
Julio Somoano
NPI 1851399224
$1,877.80
in general payments reported to CMS, 2019-2025
15 companies · $69.44 in 2025
The $69.44 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $654 · 2020: $110 · 2021: $369 · 2022: $276 · 2023: $216 · 2024: $183 · 2025: $69.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $758.32 | 2019-2023 | Lo Loestrin Fe |
| Astellas Pharma US INC | $204.74 | 2023-2024 | Veozah |
| Vertical Pharmaceuticals, LLC | $174.26 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $142.66 | 2021-2024 | |
| Allergan, INC. | $141.97 | 2019-2020 | |
| Lupin INC. | $121.34 | 2019-2020 | |
| Medicem INC. | $89.63 | 2022 | |
| Coopersurgical, INC. | $69.44 | 2025 | Ally II Ups |
| Duchesnay USA Incorporated | $42.55 | 2019 | |
| Pfizer INC. | $26.82 | 2022 | |
| Covidien LP | $24.64 | 2019 | |
| Exeltis, USA INC. | $23.77 | 2023 | Slynd |
| Myovant Sciences INC. | $21.09 | 2022 | |
| Organogenesis INC. | $19.45 | 2024 | |
| Hologic Sales and Service, LLC | $17.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julio Somoano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.